Literature DB >> 19937226

Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population.

C Hu1, C Wang, R Zhang, M C Ng, Y Bao, C Wang, W Y So, R C Ma, X Ma, J C Chan, K Xiang, W Jia.   

Abstract

AIMS/HYPOTHESIS: Chromosome 1q21-q24 has been shown to be linked to type 2 diabetes. The International Type 2 Diabetes 1q Consortium showed that one of the nominal associations was located in the NOS1AP gene. Although this association was not replicated in additional samples of European descent, it remains unknown whether NOS1AP plays a role in Chinese individuals.
METHODS: In stage 1 analyses, 79 single nucleotide polymorphisms (SNPs) of the NOS1AP gene were successfully genotyped in a group of Shanghai Chinese individuals, comprising 1,691 type 2 diabetes patients and 1,720 control participants. In stage 2 analyses, the SNP showing the strongest association was genotyped in additional Chinese individuals, including 1,663 type 2 diabetes patients and 1,408 control participants.
RESULTS: In stage 1 analyses, 20 SNPs were nominally associated with type 2 diabetes (p < 0.05), with SNP rs12742393 showing the strongest association (OR 1.24 [95% CI 1.11-1.38]; p = 0.0002, empirical p = 0.019). Haplotype analysis also confirmed the association between rs12742393 and type 2 diabetes. In stage 2 analyses, the difference in allele frequency distribution of rs12742393 did not reach statistical significance (p = 0.254). However, the meta-analysis showed a significant association between rs12742393 and type 2 diabetes with an OR of 1.17 (95% CI 1.07-1.26; p = 0.0005). CONCLUSIONS/
INTERPRETATION: Our data suggest that NOS1AP variants may not play a dominant role in susceptibility to type 2 diabetes, but a minor effect cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937226     DOI: 10.1007/s00125-009-1594-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

1.  Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction.

Authors:  Mingming Hao; W Steven Head; Subhadra C Gunawardana; Alyssa H Hasty; David W Piston
Journal:  Diabetes       Date:  2007-06-15       Impact factor: 9.461

2.  A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.

Authors:  C Hu; R Zhang; C Wang; X Ma; C Wang; Q Fang; Y Bao; K Xiang; W Jia
Journal:  Diabetologia       Date:  2008-12-13       Impact factor: 10.122

3.  Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers.

Authors:  M L Becker; L E Visser; C Newton-Cheh; J C M Witteman; A Hofman; A G Uitterlinden; B H Ch Stricker
Journal:  Diabetologia       Date:  2008-09-03       Impact factor: 10.122

Review 4.  The genetics of type 2 diabetes.

Authors:  A L Gloyn; M I McCarthy
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-09       Impact factor: 4.690

5.  CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95.

Authors:  S R Jaffrey; A M Snowman; M J Eliasson; N A Cohen; S H Snyder
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

Review 6.  Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.

Authors:  Noboru Toda; Megumi Nakanishi-Toda
Journal:  Prog Retin Eye Res       Date:  2007-01-20       Impact factor: 21.198

7.  A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus.

Authors:  Hirohiko Iwasaki; Masayoshi Kajimura; Satoshi Osawa; Shigeru Kanaoka; Takahisa Furuta; Mutsuhiro Ikuma; Akira Hishida
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.

Authors:  R Shankar; J S Zhu; B Ladd; D Henry; H Q Shen; A D Baron
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

10.  Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.

Authors:  Matthijs L Becker; Albert-Jan L H J Aarnoudse; Christopher Newton-Cheh; Albert Hofman; Jacqueline C M Witteman; André G Uitterlinden; Loes E Visser; Bruno H Ch Stricker
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

View more
  24 in total

1.  A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.

Authors:  J Lu; C Hu; W Hu; R Zhang; C Wang; W Qin; W Yu; K Xiang; W Jia
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

2.  Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.

Authors:  Danfeng Peng; Jie Wang; Rong Zhang; Feng Jiang; Shanshan Tang; Miao Chen; Jing Yan; Xue Sun; Shiyun Wang; Tao Wang; Dandan Yan; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  Diabetologia       Date:  2015-03-28       Impact factor: 10.122

3.  NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells.

Authors:  David J Margolis; Michelle Hampton; Ole Hoffstad; D Scot Mala; Ziad Mirza; Diana Woltereck; Steven Shannon; Michael A Troiano; Nandita Mitra; Ming Yang; Veena M Bhopale; Stephen R Thom
Journal:  Wound Repair Regen       Date:  2017-08-14       Impact factor: 3.617

Review 4.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

5.  A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.

Authors:  Wen Qin; Rong Zhang; Cheng Hu; Cong-rong Wang; Jing-yi Lu; Wei-hui Yu; Yu-qian Bao; Kun-san Xiang; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

6.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

7.  Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.

Authors:  Cheng Hu; Rong Zhang; Congrong Wang; Weihui Yu; Jingyi Lu; Xiaojing Ma; Jie Wang; Feng Jiang; Shanshan Tang; Yuqian Bao; Kunsan Xiang; Weiping Jia
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

8.  PS-341 alleviates chronic low-grade inflammation and improves insulin sensitivity through the inhibition of TM4 (UBAC2) degradation.

Authors:  Lili Chen; Kuanping Ye; Xiaocheng Feng; Lianxi Li; Qin Li; Ying Huang; Xuanchun Wang; Rumei Li; Cheng Hu; Zhen Yang; Bin Lu; Yehong Yang; Jie Wen; Zhaoyun Zhang; Min He; Qinghua Wang; Wenbai Zhou; Yintao Li; Naijia Liu; Jinya Huang; Qiwei Shen; Qiyuan Yao; Renming Hu
Journal:  Nutr Metab (Lond)       Date:  2021-06-01       Impact factor: 4.169

9.  Serum Proteome Changes in Healthy Subjects with Different Genotypes of NOS1AP in the Chinese Population.

Authors:  Feng Jiang; Congrong Wang; Rongxia Li; Quanhu Sheng; Cheng Hu; Rong Zhang; Qichen Fang; Yuqian Bao; Kunsan Xiang; Rong Zeng; Weiping Jia
Journal:  J Diabetes Res       Date:  2013-04-07       Impact factor: 4.011

10.  Neutrophil microparticle production and inflammasome activation by hyperglycemia due to cytoskeletal instability.

Authors:  Stephen R Thom; Veena M Bhopale; Kevin Yu; Weiliang Huang; Maureen A Kane; David J Margolis
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.